For 9 long years, I've been warned about being pre-diabetic
Although its currently approved for type 2 diabetes, its potential for weight loss is generating significant interest
(Exenatide is FDA approved as monotherapy for the management of T2DM.) Explicitly stated in the guideline for patients requiring dual or triple therapy, the AACE/ACE preferentially recommends the addition of a GLP-1 receptor agonist or a DPP-4 inhibitor (sitagliptin, saxagliptin), citing their efficacy and safety profiles as preferred agents over TZDs or sulfonylureas (SUs)
Injections typically produce faster satiety effects and allow providers to adjust doses more precisely than oral tablets
At each facility, scans were performed using a General Electric (GE) DXA scanner
Youll leave with a clear diagnosis whether your Mounjaro-related shedding is temporary telogen effluvium, underlying female pattern hair loss, or both and a treatment pathway that works alongside your medication